If you could vote on Brexit now which option would you choose?
   

Pre-clinical trials show intranasal COVID-19 vaccine reduces infection risk


Scientists from Lancaster University have carried out pre-clinical trials of a COVID-19 vaccine which can be administered through the nose. The results of the trials showed a reduction in both the impact of COVID-19 itself and transmission of the virus.

HealthEuropa - August 12, 2021

View the full story here: https://www.healtheuropa.eu/pre-clinical-trials-show-intranasal-covid-19-vaccine-reduces-infection-risk/110430/